ATP synthase inhibitor 1

CAS No. 1023043-30-2

ATP synthase inhibitor 1( —— )

Catalog No. M26064 CAS No. 1023043-30-2

ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 122 In Stock
10MG 202 In Stock
25MG 404 In Stock
50MG 584 In Stock
100MG 833 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ATP synthase inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.
  • Description
    ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.(In Vitro):ATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    estrogen receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1023043-30-2
  • Formula Weight
    411.92
  • Molecular Formula
    C17H18ClN3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (12.14 mM)
  • SMILES
    Clc1ccc(s1)S(=O)(=O)N1CCC2(CC1)N(CNC2=O)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NDI-091143

    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.

  • Blebbistatin

    Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.

  • Lanatoside C

    Lanatoside C is a cardiac glycoside, a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat).